Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database

Table 2 Comparison of the clinicopathological characteristics of patients with perioperative blood transfusion and without perioperative blood transfusion

Variables	Group with perioperative blood transfusion n = 298	Group without perioperative blood transfusion n = 1283	P value
Gender			0.749
Male	210	892
Female	88	391
Age (yr)			< 0.001
≤ 60	119	772
>60	179	511
Tumor size (cm)			< 0.001
≤ 5	148	988
>5	150	295
Tumor location			< 0.001
Upper third	116	447
Middle third	68	207
Lower third	95	607
Two-third or more	19	22
TNM stage			< 0.001
Stage I	37	366
Stage II	84	298
Stage III	177	619
Type of Gastrectomy			< 0.001
Subtotal	221	1121
Total	77	162
Operation time (min)			0.001
< 180	168	857
≥ 180	130	426
Albumin level at admission (g/dl)			0.001
< 3.5	94	285
≥ 3.5	204	998
Hemoglobin level at admission (g/dl)			< 0.001
< 12	211	364
≥ 12	87	919

TNM Tumor Node Metastasis, n number of patients; P value obtained by chi-squares tests or Fisher’s exact test, min minute

ISSN: 1471-2407